The results met Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for earnings of 28 cents per share. The chipmaker posted revenue of $133.

Phase 3 PEAK results in 2nd-line GIST patients expected in November; pivotal APEX results in AdvSM patients expected in December ...

NorthWest Healthcare could become a lifetime-income REIT, but heavy debt, a 2023 distribution cut, and a deep NAV discount ...

See if Kohl's Corporation stock is a smart buy as free cash flow shines but future growth faces doubts. Click for more on KSS ...

First Hawaiian Bank’s third quarter was marked by a positive market response, as the company surpassed analysts’ revenue and ...

The ITAT Delhi confirmed the addition of Rs.25.35 lakh as unexplained investment for a house purchase under Section 69, ruling that the assessee failed to discharge the initial onus to prove the ...

News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, ...

Consolidated Revenue -- EUR 66.3 million, down 3.5% compared to Q3 2024, with Materialise Medical achieving an all-time ...

Nintendo(OTC: NTDOY) and Crocs(NASDAQ: CROX) are two stocks I am buying hand over fist before they could soar higher in 2026. Here's why these are great buys for investors as we head to the end of the ...

In 2020, Australia massively increased welfare payments and conducted a live experiment in ending poverty, but when the ...

Aritzia could be a ten-bagger, a scalable “everyday luxury” brand growing fast in the U.S. with strong margins and repeat ...

"How do I decide what approach I should take?" (Photo subject is a model.) ...